Intel (INTC) Makes $2.3B Quantum Bet With Classiq Deal to Rival IonQ
Intel Corporation ($INTC) is making a $2.3 billion bet on quantum computing, agreeing to buy Israeli software company Classiq in a deal that could ...
Merck Sharp & Dohme Corp. (MRK)
This company is not actively trading or the ticker does belong to another company in our database now. The symbol (MRK) is currently associated with the following stock: Merck & Co. Inc. (MRK)
Sector: Pharmaceutical Preparations
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.22 | 550 | $18,268.75 | 750 | 2006-01-18 | Filing | |
| $45.65 | 200 | $9,130.56 | 200 | 2002-09-24 | Filing |
News See All
Moderna Stock (MRNA) Falls 3% as Analysts Question $80 Billion Valuation Despite CEO’s Defense of Cancer Vaccine
Moderna ($MRNA) shares fell 3% in pre-market trading today after Wall Street analysts warned that its Phase 3 melanoma trial results were weaker th...
Options Volatility and Implied Earnings Moves This Week, October 26 – October 30, 2026
This week, several major companies will be reporting earnings. Among them are Amazon (AMZN), Microsoft (MSFT), Alphabet Class A (GOOGL), Alphabet C...
Pfizer (PFE) Lung Cancer Drug Shows Survival Benefit Despite Trial Failure
Pfizer ($PFE) is keeping its experimental lung cancer drug alive despite a failed clinical trial. New data showed that some patients treated with s...
The Week That Was, The Week Ahead: Macro and Markets, October 25
U.S. stocks finished Friday lower as rising oil prices and renewed inflation concerns weighed on Wall Street. The Dow Jones Industrial Average (DJI...
Moderna’s Cancer Vaccine Earns Praise from Doctors amid Stock Selloff
Biotech company Moderna ($MRNA) saw its shares fall by as much as 25% on Thursday, October 22, despite positive results from a late-stage trial of ...
Why Is Moderna Stock (MRNA) Still Falling After Thursday’s 18% Plunge?
Shares of U.S. vaccine maker Moderna ($MRNA) fell another 6% to about $191 during Friday’s pre-market session, extending Thursday’s 17.57% plunge. ...
Moderna (MRNA) vs. BioNTech (BNTX): Which Biotech Stock Offers Upside, According to Wall Street?
Moderna ($MRNA) and BioNTech ($BNTX) are biotech stocks focused on cancer vaccines as they enter their next growth phase. According to TipRanks Com...
Moderna Stock (MRNA) Plunges 25% as Data Is Leaked Online
Expectations are high for the company’s new cancer drug.
Merck (MRK) Has New Cancer Treatments. Can They Outgrow the Keytruda Patent Cliff?
A Growing Franchise With an Expiration Date Merck & Co., Inc. (NYSE:MRK) is trying to extend its oncology leadership before competition threatens its largest earnings engine.
Hedge Fund Resource Center